HUONS CO., LTD. Logo

HUONS CO., LTD.

Global healthcare company providing pharmaceuticals, medical devices, and wellness products.

243070 | KO

Overview

Corporate Details

ISIN(s):
KR7243070000
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 17 판교 아이스퀘어 A동 8층, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Huons Co., Ltd. is a global healthcare company established in 1965 with a mission of "making tomorrow healthier." The firm develops, manufactures, and supplies a wide range of medical solutions for human health. Its portfolio encompasses finished pharmaceutical products, including oral solid form drugs and eye drops, alongside medical devices and wellness items such as health supplements and cosmetics. As part of the Huons Group, the company prioritizes research and development to discover new growth engines and expand its international footprint. Huons is recognized for its cGMP-standard manufacturing facilities and a history of innovation, such as pioneering the first plastic injection container in Korea.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.7 MB
2025-08-13 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 10.8 KB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (중간배당)
Korean 8.9 KB
2025-08-06 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 17.9 KB
2025-07-29 00:00
Report Publication Announcement
결산실적공시예고
Korean 4.4 KB
2025-06-27 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-06-20 00:00
Regulatory News Service
신탁계약해지결과보고서
Korean 22.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.1 MB
2025-05-08 00:00
M&A Activity
합병등종료보고서(분할)
Korean 54.4 KB
2025-05-02 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 17.4 KB
2025-04-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 112.9 KB
2025-04-25 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-04-25 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB

Automate Your Workflow. Get a real-time feed of all HUONS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HUONS CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HUONS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Tango Therapeutics, Inc. Logo
Developing precision oncology therapies for genetically-defined patients via synthetic lethality.
United States of America
TNGX
Tarsus Pharmaceuticals, Inc. Logo
Develops novel therapies for eye care, including the first FDA-approved Demodex blepharitis drug.
United States of America
TARS
TAUNS Laboratories, Inc. Logo
Develops and sells in vitro diagnostics and research reagents, like antigen tests, globally.
Japan
197A
Taysha Gene Therapies, Inc. Logo
Developing AAV-based gene therapies for rare, severe monogenic diseases of the central nervous system.
United States of America
TSHA
Tchaikapharma High Quality Medicines AD Logo
Develops and makes affordable generic drugs for cardiovascular & metabolic diseases.
Bulgaria
THQM
TDSPHARM Co., Ltd. Logo
Develops and manufactures transdermal drug delivery systems like patches, plasters, and OTC products.
South Korea
464280
Tectonic Therapeutic, Inc. Logo
Developing biologic therapies that modulate GPCRs for diseases with unmet needs.
United States of America
TECX
Tego Science, Inc. Logo
Develops cell therapies for skin regeneration, 3D models for testing, and provides CDMO services.
South Korea
191420
Develops radiopharmaceuticals that use targeted radiation to image and treat various cancers.
United States of America
TLX
Telomir Pharmaceuticals, Inc. Logo
Developing an oral small molecule to reverse aging and treat age-related diseases.
United States of America
TELO

Talk to a Data Expert

Have a question? We'll get back to you promptly.